Prev Next

BP-C1 Oncology

BP-C1 Cancer care Unique product that clinically has proven to have both strong palliation properties as well as tumor control properties. more

BP-C2 Radiation Defence

BP-C2 incorporates immunomodulating and chelating ligand and a molybdenum, needed for detoxification. more

About us

Meabco A/S is a privately owned Danish pharmaceutical company with a development portfolio within cancer and radioprotection.

Meabco A/S is developing solutions with a strong emphasis on human wellbeing and quality of life, and with huge potential savings on the socio-economical costs.

Meabco’s patented technology platform, offers favorable and immunomodulating properties.
The efficacy of drugs utilizing our technology has been seen to not only combat cancer and to protect from and heal radiation-induced injuries but also to balance the immune system, blood values, and other body functions.

MEABCO A/S  |  Richard Mortensens Vej 61  |  DK-2300 Copenhagen  |  Telephone: +45 32 46 03 70  | e-mail:
Websitet anvender cookies til at huske dine indstillinger, statistik og at målrette annoncer. Når du besøger vores hjemmeside, accepterer du automatisk vores brug af Cookies.